ACL australian clinical labs limited
Add to My Watchlist 0.00% ! $2.83

News: ACL Australian Clinical Labs Says Reviewing Healius' Target's Statement

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    05/05/23
    11:35
    Post #: 67624102

    May 5 (Reuters) - Australian Clinical Labs Ltd (ACL) :

    • REVIEWING & CONSIDERING INFORMATION CONTAINED IN HEALIUS TARGET’S STATEMENT WITH ITS ADVISERS
    • ACL'S OFFER FOR HEALIUS IS OPEN FOR ACCEPTANCE UNTIL 7.00PM (SYDNEY TIME) ON 29 SEPT
    • NOTES HEALIUS IDENTIFIES NUMBER OF CONDITIONS OF OFFER THAT IT CONSIDERS ARE NOT LIKELY TO BE SATISFIED
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS What is going on here? Watch out for DroneShield, Pure Hydrogen, and Nel ASA
right-arrow Created with Sketch.
NEWS Firetail scoops up untested land around Excelsior – including juicy mineralisation target
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
NEWS Renascor produces graphite concentrate at Siviour, right on time to meet ex-China demand
right-arrow Created with Sketch.
NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$2.83 		Change
0.000(0.00%) 		Mkt cap ! $555.7M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 692 $2.89
 

Sellers (Offers)

Price($) Vol. No.
$2.69 3 1
View Market Depth
Last trade - 08.33am 28/07/2025 (20 minute delay) ?
ACL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.